31
Views
32
CrossRef citations to date
0
Altmetric
Cell Growth and Development

Mutations in the SAM Domain of the ETV6-NTRK3 Chimeric Tyrosine Kinase Block Polymerization and Transformation Activity

, , , &
Pages 4636-4650 | Received 17 Oct 2003, Accepted 02 Mar 2004, Published online: 27 Mar 2023

REFERENCES

  • Beissert, T., Puccetti E., Bianchini A., Guller S., Boehrer S., Hoelzer D., Ottmann O. G., Nervi C., and Ruthardt M.. 2003. Targeting of the N-terminal coiled coil oligomerization interface of BCR interferes with the transformation potential of BCR/ABL and increases sensitivity to STI571. Blood 102:2985–2993.
  • Blume-Jensen, P., and Hunter T.. 2001. Oncogenic kinase signalling. Nature 411:355–365.
  • Bohlander, S. K. 2000. Fusion genes in leukemia: an emerging network. Cytogenet. Cell Genet. 91:52–56.
  • Cazzaniga, G., Tosi S., Aloisi A., Giudici G., Daniotti M., Pioltelli P., Kearney L., and Biondi A.. 1999. The tyrosine kinase abl-related gene ARG is fused to ETV6 in an AML-M4Eo patient with a t(1;12)(q25;p13): molecular cloning of both reciprocal transcripts. Blood 94:4370–4373.
  • Chi, S. W., Ayed A., and Arrowsmith C. H.. 1999. Solution structure of a conserved C-terminal domain of p73 with structural homology to the SAM domain. EMBO J. 18:4438–4445.
  • Eguchi, M., Eguchi-Ishimae M., Tojo A., Morishita K., Suzuki K., Sato Y., Kudoh S., Tanaka K., Setoyama M., Nagamura F., Asano S., and Kamada N.. 1999. Fusion of ETV6 to neurotrophin-3 receptor TRKC in acute myeloid leukemia with t(12;15)(p13;q25). Blood 93:1355–1363.
  • Golub, T. R., Barker G. F., Bohlander S. K., Hiebert S. W., Ward D. C., Bray-Ward P., Morgan E., Raimondi S. C., Rowley J. D., and Gilliland D. G.. 1995. Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. Proc. Natl. Acad. Sci. USA 92:4917–4921.
  • Golub, T. R., Barker G. F., Lovett M., and Gilliland D. G.. 1994. Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 77:307–316.
  • Golub, T. R., Goga A., Barker G. F., Afar D. E., McLaughlin J., Bohlander S. K., Rowley J. D., Witte O. N., and Gilliland D. G.. 1996. Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia. Mol. Cell. Biol. 16:4107–4116.
  • Green, J. B., Gardner C. D., Wharton R. P., and Aggarwal A. K.. 2003. RNA recognition via the SAM domain of Smaug. Mol. Cell 11:1537–1548.
  • Grignani, F., Gelmetti V., Fanelli M., Rogaia D., De Matteis S., Ferrara F. F., Bonci D., Nervi C., and Pelicci P. G.. 1999. Formation of PML/RAR alpha high molecular weight nuclear complexes through the PML coiled-coil region is essential for the PML/RAR alpha-mediated retinoic acid response. Oncogene 18:6313–6321.
  • Iijima, Y., Ito T., Oikawa T., Eguchi M., Eguchi-Ishimae M., Kamada N., Kishi K., Asano S., Sakaki Y., and Sato Y.. 2000. A new ETV6/TEL partner gene, ARG (ABL-related gene or ABL2), identified in an AML-M3 cell line with a t(1;12)(q25;p13) translocation. Blood 95:2126–2131.
  • Janssen, J. W., Ridge S. A., Papadopoulos P., Cotter F., Ludwig W. D., Fonatsch C., Rieder H., Ostertag W., Bartram C. R., and Wiedemann L. M.. 1995. The fusion of TEL and ABL in human acute lymphoblastic leukaemia is a rare event. Br. J. Haematol. 90:222–224.
  • Jousset, C., Carron C., Boureux A., Quang C. T., Oury C., Dusanter-Fourt I., Charon M., Levin J., Bernard O., and Ghysdael J.. 1997. A domain of TEL conserved in a subset of ETS proteins defines a specific oligomerization interface essential to the mitogenic properties of the TEL-PDGFR beta oncoprotein. EMBO J. 16:69–82.
  • Kim, C. A., Gingery M., Pilpa R. M., and Bowie J. U.. 2002. The SAM domain of polyhomeotic forms a helical polymer. Nat. Struct. Biol. 9:453–457.
  • Kim, C. A., Phillips M. L., Kim W., Gingery M., Tran H. H., Robinson M. A., Faham S., and Bowie J. U.. 2001. Polymerization of the SAM domain of TEL in leukemogenesis and transcriptional repression. EMBO J. 20:4173–4182.
  • Klambt, C. 1993. The Drosophila gene pointed encodes two ETS-like proteins which are involved in the development of the midline glial cells. Development 117:163–176.
  • Knezevich, S. R., Garnett M. J., Pysher T. J., Beckwith J. B., Grundy P. E., and Sorensen P. H.. 1998. ETV6-NTRK3 gene fusions and trisomy 11 establish a histogenetic link between mesoblastic nephroma and congenital fibrosarcoma. Cancer Res. 58:5046–5048.
  • Knezevich, S. R., McFadden D. E., Tao W., Lim J. F., and Sorensen P. H.. 1998. A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma. Nat. Genet. 18:184–187.
  • Kyba, M., and Brock H. W.. 1998. The Drosophila Polycomb group protein Psc contacts ph and Pc through specific conserved domains. Mol. Cell. Biol. 18:2712–2720.
  • Lannon, C. L., Martin M. J., Tognon C. E., Jin W., Kim S. J., and Sorensen P. H.. 2004. A highly conserved NTRK3 C-terminal sequence in the ETV6-NTRK3 oncoprotein binds the PTB domain of IRS-1: an essential interaction for transformation. J. Biol. Chem. 279:6225–6234.
  • Lin, R. J., and Evans R. M.. 2000. Acquisition of oncogenic potential by RAR chimeras in acute promyelocytic leukemia through formation of homodimers. Mol. Cell 5:821–830.
  • Mackereth, C. D., Scharpf M., Gentile L. N., and McIntosh L. P.. 2002. Chemical shift and secondary structure conservation of the PNT/SAM domains from the ets family of transcription factors. J. Biomol. NMR 24:71–72.
  • Maurer, A. B., Wichmann C., Gross A., Kunkel H., Heinzel T., Ruthardt M., Groner B., and Grez M.. 2002. The Stat5-RARalpha fusion protein represses transcription and differentiation through interaction with a corepressor complex. Blood 99:2647–2652.
  • McWhirter, J. R., Galasso D. L., and Wang J. Y.. 1993. A coiled-coil oligomerization domain of Bcr is essential for the transforming function of Bcr-Abl oncoproteins. Mol. Cell. Biol. 13:7587–7595.
  • Morrison, K. B., Tognon C. E., Garnett M. J., Deal C., and Sorensen P. H. B.. 2002. ETV6-NTRK3 transformation requires insulin-like growth factor 1 receptor signaling and is associated with constitutive IRS-1 tyrosine phosphorylation. Oncogene 21:5684–5695.
  • Nagaya, H., Wada I., Jia Y. J., and Kanoh H.. 2002. Diacylglycerol kinase delta suppresses ER-to-Golgi traffic via its SAM and PH domains. Mol. Biol. Cell 13:302–316.
  • Pear, W. S., Nolan G. P., Scott M. L., and Baltimore D.. 1993. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90:8392–8396.
  • Peeters, P., Raynaud S. D., Cools J., Wlodarska I., Grosgeorge J., Philip P., Monpoux F., Van Rompaey L., Baens M., Van den Berghe H., and Marynen P.. 1997. Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15:12) in a myeloid leukemia. Blood 90:2535–2540.
  • Ponting, C. P. 1995. SAM: a novel motif in yeast sterile and Drosophila polyhomeotic proteins. Protein Sci. 4:1928–1930.
  • Rabbitts, T. H. 1994. Chromosomal translocations in human cancer. Nature 372:143–149.
  • Ramachander, R., Kim C. A., Phillips M. L., Mackereth C. D., Thanos C. D., McIntosh L. P., and Bowie J. U.. 2002. Oligomerization-dependent association of the SAM domains from Schizosaccharomyces pombe Byr2 and Ste4. J. Biol. Chem. 277:39585–39593.
  • Raynaud, S., Cave H., Baens M., Bastard C., Cacheux V., Grosgeorge J., Guidal-Giroux C., Guo C., Vilmer E., Marynen P., and Grandchamp B.. 1996. The 12;21 translocation involving TEL and deletion of the other TEL allele: two frequently associated alterations found in childhood acute lymphoblastic leukemia. Blood 87:2891–2899.
  • Sakane, F., Kai M., Wada I., Imai S., and Kanoh H.. 1996. The C-terminal part of diacylglycerol kinase alpha lacking zinc fingers serves as a catalytic domain. Biochem. J. 318(Pt 2):583–590.
  • Salomon-Nguyen, F., Della-Valle V., Mauchauffe M., Busson-Le Coniat M., Ghysdael J., Berger R., and Bernard O. A.. 2000. The t(1;12)(q21;p13) translocation of human acute myeloblastic leukemia results in a TEL-ARNT fusion. Proc. Natl. Acad. Sci. USA 97:6757–6762.
  • Schultz, J., Ponting C. P., Hofmann K., and Bork P.. 1997. SAM as a protein interaction domain involved in developmental regulation. Protein Sci. 6:249–253.
  • Sharrocks, A. D. 2001. The ETS-domain transcription factor family. Nat. Rev. Mol. Cell Biol. 2:827–837.
  • Sjoblom, T., Boureux A., Ronnstrand L., Heldin C. H., Ghysdael J., and Ostman A.. 1999. Characterization of the chronic myelomonocytic leukemia associated TEL-PDGF beta R fusion protein. Oncogene 18:7055–7062.
  • Slupsky, C. M., Gentile L. N., Donaldson L. W., Mackereth C. D., Seidel J. J., Graves B. J., and McIntosh L. P.. 1998. Structure of the Ets-1 pointed domain and mitogen-activated protein kinase phosphorylation site. Proc. Natl. Acad. Sci. USA 95:12129–12134.
  • Smith, K. M., and Van Etten R. A.. 2001. Activation of c-Abl kinase activity and transformation by a chemical inducer of dimerization. J. Biol. Chem. 276:24372–24379.
  • Spencer, D. M., Wandless T. J., Schreiber S. L., and Crabtree G. R.. 1993. Controlling signal transduction with synthetic ligands. Science 262:1019–1024.
  • Stapleton, D., Balan I., Pawson T., and Sicheri F.. 1999. The crystal structure of an Eph receptor SAM domain reveals a mechanism for modular dimerization. Nat. Struct. Biol. 6:44–49.
  • Tessier-Lavigne, M. 1995. Eph receptor tyrosine kinases, axon repulsion, and the development of topographic maps. Cell 82:345–348.
  • Thanos, C. D., Faham S., Goodwill K. E., Cascio D., Phillips M., and Bowie J. U.. 1999. Monomeric structure of the human EphB2 sterile alpha motif domain. J. Biol. Chem. 274:37301–37306.
  • Thanos, C. D., Goodwill K. E., and Bowie J. U.. 1999. Oligomeric structure of the human EphB2 receptor SAM domain. Science 283:833–836.
  • Tognon, C., Garnett M., Kenward E., Kay R., Morrison K., and Sorensen P. H.. 2001. The chimeric protein tyrosine kinase ETV6-NTRK3 requires both Ras-Erk1/2 and PI3-kinase-Akt signaling for fibroblast transformation. Cancer Res. 61:8909–8916.
  • Tognon, C., Knezevich S. R., Huntsman D., Roskelley C. D., Melnyk N., Mathers J. A., Becker L., Carneiro F., MacPherson N., Horsman D., Poremba C., and Sorensen P. H.. 2002. Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell. 2:367–376.
  • Tran, H. H., Kim C. A., Faham S., Siddall M. C., and Bowie J. U.. 2002. Native interface of the SAM domain polymer of TEL. BMC Struct. Biol. 2:5.
  • Tu, H., Barr M., Dong D. L., and Wigler M.. 1997. Multiple regulatory domains on the Byr2 protein kinase. Mol. Cell. Biol. 17:5876–5887.
  • Wai, D. H., Knezevich S. R., Lucas T., Jansen B., Kay R. J., and Sorensen P. H. B.. 2000. The ETV6-NTRK3 gene fusion encodes a chimeric protein tyrosine kinase that transforms NIH3T3 cells. Oncogene 19:906–915.
  • Wang, L. C., Swat W., Fujiwara Y., Davidson L., Visvader J., Kuo F., Alt F. W., Gilliland D. G., Golub T. R., and Orkin S. H.. 1998. The TEL/ETV6 gene is required specifically for hematopoiesis in the bone marrow. Genes Dev. 12:2392–2402.
  • Yagasaki, F., Wakao D., Yokoyama Y., Uchida Y., Murohashi I., Kayano H., Taniwaki M., Matsuda A., and Bessho M.. 2001. Fusion of ETV6 to fibroblast growth factor receptor 3 in peripheral T-cell lymphoma with a t(4;12)(p16;p13) chromosomal translocation. Cancer Res. 61:8371–8374.
  • Zhao, X., Ghaffari S., Lodish H., Malashkevich V. N., and Kim P. S.. 2002. Structure of the Bcr-Abl oncoprotein oligomerization domain. Nat. Struct. Biol. 9:117–120.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.